Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Recruiting · NCT06023758 · Registry updated 2024-05-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC | HER2-positive Locally Advanced Resectable Gastric Cancer | Recruiting | Phase 2 | 2024-05-10 | NCT06023758 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University | 124 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |